Healthcare

Improving turn-around time for laboratory outcomes, testing for impending cardiac arrest and detecting cervical cancer are just several of the important topics reviewed at the Fourth annual Roche Days conference. Roche Days, presented by Roche Diagnostics Middle East, is a platform for key opinion leaders throughout the region. Greater than 300 of the region's medical specialists in the in-vitro diagnostics (IVD) industry in the Middle East were hosted over the weekend.

The meeting was inaugurated by Sheikha Rasha Al Qassimi, Phd, Food Scientific research & Modern technology (UK) and Assistant Director General of Public Health and Central Laboratories, Sharjah Town, helped by Harald Wolf, General Manager, Roche Diagnostics Middle East Roche Days was held as part of Roche Diagnostics' dedication to supplying continued clinical education and highlighting regional expertise to share knowledge and talk about challenges along with options in diagnostics especially in the areas of heart diseases, womens health such as cervical cancer, and lab automation.

"With our Roche Days, we had the ability to waterfall the lots of advantages of research laboratory automation in the industry and allow for cross-border cooperation to combine the brightest minds in the region to discuss obstacles and options. We reside in a hectic period when technology continues to bring higher advantages for us. Roche Diagnostics blazes a trail in in-vitro diagnostics in regards to research and innovation to provide the broadest variety of lab options which dramatically boost turnaround time for tests and results, give effectiveness, top quality and safety and security," said Mr. Wolf.

A particular emphasis of this year's Roche Days got on laboratory automation and much more effective lab treatments to release analysis information to physicians quicker while additionally minimizing mistake and sample contamination.

With automation, Dr. Amid Abdelnour, Chief Executive Officer - Biolab, Jordan, noted that an exceptional increase in client safety and security along with performance and capability are being observed upon execution in labs.

Developments in diagnostics additionally led the way for testing cardiovascular disease quicker with even more exact and dependable outcomes. It is estimated that 23.6 million will pass away by 2030 from heart diseases [i] and accurate very early detection and intervention is critical. With high-sensitivity assays, physicians are currently able to enhance the discovery of myocardial injury (detection at earlier time) and can assist recognize threat of heart diseases (forecast of unfavorable outcomes). Dr. Rabih Azar, Professor of Medicine, St. Joseph University, Chief of Cardiology Research, Division of Cardiology - Hotel Dieu de France Healthcare facility, Lebanon, kept in mind that with readily available high-sensitive examination, a secure and rapid diagnosis could be done within one hour observation time which is quicker compared to the normal 3-6 hours of observation utilizing the standard analysis technique. This was discussed extensively during the acute coronary disorder panel session on cardiology including Dr. Laila Abdel-Wareth of Cleveland Center Abu Dhabi, to name a few.

In regards to females's health, cervical cancer cells continues to be a difficulty throughout the region as a result of lack of understanding amongst ladies and - until recent years - the absence of a particular diagnostics examinations or testing. While cervical cancer cells is extremely preventable, roughly 500,000 new situations worldwide are detected each year. [ii] With advanced analysis tools available today, physicians could enhance the ability to identify cervical cancer early to stop advancement and progression of the disease.

To this end, Dr. Hisham Shams, Group Medical Director at Alborg Medical Laboratories, Saudi Arabia, revealed new devices and new thinking in attending to cervical cancer. With restrictions in the past on cervical cytology, there is a much better way now to spot the existence of Human Papillomavirus (HPV) and its consistent infection to a person which is the primary source of cervical cancer cells in women. Making use of HPV molecular diagnostics instead of the traditional approaches, aids boost level of sensitivity of detection by 50% and reduces the risk of cancer advancing after testing negative of HPV.

"The conference delved deeper on various other medical care subjects as well giving a relevant platform to alter the state of mind of diagnostics being just a device for medical diagnosis. From prevention to tracking, diagnostics is an integral part of decision making along the health care continuum and to enhance the potential of diagnostics in the fight against disease," claims Mr. Wolf.

Roche Diagnostics Middle East likewise hosted the MeDia Talks, an academic platform for the in-vitro diagnostics industry for regional media, with an interactive educational session in its initiatives to raise the awareness on the relevance of diagnostics and its benefits to the health care industry as a whole including its cost efficiency. A laboratory tour was conducted to further reveal the media the effectiveness of the automation procedure.

Photo Captions: Sheikha Rasha Al Qassimi, PhD, Food Science & Modern technology (UK) and Assistant Director of Public Health and Central Laboratories, Sharjah Community with Mr. Harald Wolf, General Manager, Roche Diagnostics Middle East.

• Tags
• #Business
• #Magazine
• #Lifestyle